Lamivudine [lamivudin]
topical
95
- Terms
-
2(1H)-pyrimidinon, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-
3TC lamivudin
BCH-189
Epivir
GR-109714X
GR109714X
lamivudin, (+-)-trans-
lamivudin, (+)-cis-
lamivudin, (2S-cis)-izomer
-
2',3'-Dideoxy-3'-thiacytidine
2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-
3TC Lamivudine
BCH-189
Epivir
GR-109714X
GR109714X
Lamivudine, (+-)-trans-
Lamivudine, (+)-cis-
Lamivudine, (2S-cis)-Isomer
Persistent link
https://www.medvik.cz/link/D019259
Definition
A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.
- DUI
- D019259 MeSH Browser
- CUI
- M0028682
- RN
- 2T8Q726O95
- Previous indexing
- Cytosine/analogs & derivatives (1991-1992); Zalcitabine/analogs & derivatives (1993-1996)
- History note
- 97; was LAMIVUDINE (NM) 1991-96
- Online note
- use LAMIVUDINE (NM) to search LAMIVUDINE 1991-96
- Public note
- 97; LAMIVUDINE was indexed under ZALCITABINE/analogs & derivatives 1993-96 and CYTOSINE/analogs & derivatives 1991-92
Allowable subheadings
- AD
- administration & dosage 45
- AE
- adverse effects 7
- AG
- agonists 0
- AA
- analogs & derivatives 1
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 2
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 2
- PK
- pharmacokinetics 2
- PD
- pharmacology 27
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 56
- TO
- toxicity 0
- UR
- urine 1
...
Occurrences in Medvik records
D
Chemicals and Drugs